関連する実験動画
Updated: May 6, 2026

05:19
Practical Methodology of Cognitive Tasks Within a Navigational Assessment
Published on: June 1, 2015
15.6K
高質の認知症ケアナビゲーション実装のためのフレームワーク:アルツハイマー病協会の認知症ケアナビゲーションラウンドテーブルからの推奨事項
Morgan Daven1, David M Bass2, Nicole Deaner1
1Alzheimer's Association, Chicago, Illinois, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 30, 2026
まとめ
認知症ケアナビゲーション(DCN)ラウンドテーブルは、認知症ケアの質を向上させるためのトレーニング基準と定義された役割を確立しました。推奨事項は、個人および家族中心のアプローチと、DCNサービスのための持続可能な財務モデルの作成に焦点を当てています。
科学分野:
- 老年医学
- ヘルスケアマネジメント
- 認知症ケア
背景:
- アルツハイマー病協会は、2023年に認知症ケアナビゲーション(DCN)ラウンドテーブルを招集した。
- ラウンドテーブルは、DCNサービスの実装をガイドするために、多様な認知症専門家で構成されていた。
主な方法:
- DCNラウンドテーブル内での専門家のコンセンサスと戦略的議論。
- Medicareのガイドおよび改善された認知症体験(GUIDE)モデルとのDCNサービスの連携。
- GUIDEモデルとDCNの7つの必須原則に基づく推奨事項。
結論:
- 定義された役割と標準化されたトレーニングは、質の高い認知症ケアナビゲーション(DCN)にとって重要である。
- 持続可能なビジネスケースには、支払い者への価値の実証とヘルスケア指標との連携が必要である。
- 個人および家族中心のケア原則は、すべてのDCN実装をガイドする必要がある。
関連する概念動画
Documentation in Long-Term and Home Healthcare Setting
1.6K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.6K
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Dementia
696
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
696
Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

